- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05476705
Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1 (DRP-EDiT)
Right Place, Right Practitioner, Right Time: Development of Emergency Department Triage to Support the Identification and Management of Drug Related Problems
Up to a third of patients who visit emergency departments (EDs) do so because they have an issue with medicines prescribed by their doctor or purchased over the counter. For example, some patients might experience side effects (e.g., sickness), whereas others may feel their prescribed medicine is not working and want an alternative. While some patients who visit EDs know they have a problem with their medication, some are not aware. Furthermore, drug-related problems (DRPs) may not be identified by ED triage systems which are used to sort patients' priority for treatment. The currently used system in the UK (Manchester Triage System) mentions drugs infrequently and does not support the identification of the most common DRPs. For this project, DRPs include medication errors, adverse drug events, and adverse drug reactions. This project aims to revise the triage system to support the discovery of patients' medication problems when they are triaged by a nurse upon arrival to the ED.
After identification, problems with a patient's medication should be dealt with by the healthcare professional who is most appropriate to manage that particular issue. For example, a patient who has been prescribed a new medicine but already takes 20 medicines will likely benefit from a review by a pharmacist in the ED. This project will aim to support the management of patients who might benefit from care provided by pharmacists by providing them with this care.
As well as ensuring medication problems are identified at triage, and that pharmacists are involved in helping to deal with those problems, this project will also try to understand how we can investigate how pharmacists actually make a difference to the care of ED patients.
A multi-step approach (Stages A-F) is proposed to answer the question "How can patient DRPs be identified, triaged and managed in the ED?" In summary, the steps include: STAGE A, a systematic review and scoping survey; STAGE B, researcher visits to ED sites to shadow ED staff; STAGE C, Interviews with healthcare professionals (including those shadowed in STAGE B) to validate findings of site visits and explore topics in more depth; STAGE D, developing additional drug-related content for the Manchester Triage System; STAGE E, involving a panel of experts in a RAND appropriateness method to rate the content developed in STAGE D; STAGE F, testing the revised triage system for a future pilot study involving interviews with staff visited in STAGE B.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Daniel Greenwood
- Phone Number: 01245683082
- Email: daniel.greenwood@aru.ac.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria: The following groups will be included in various stages of the project
- STAGE A: ED clinicians at UK-wide NHS trusts
- STAGE B: ED staff from 8 NHS sites across the UK
- STAGE C: ED staff from 8 NHS sites across the UK
- STAGE E: Clinicians and academics with expertise in Emergency Care and/or ED Triage
- STAGE F: ED staff from 8 NHS sites across the UK
Exclusion Criteria:
- Those who do not consent or who are unable to consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suitability of a revised Manchester Triage System (MTS)
Time Frame: 13 months (the revised MTS will be an output from the analysis of data collected months 1 - 13)
|
The suitability of a revised MTS to support identification and management of drug-related problems in the Emergency Department
|
13 months (the revised MTS will be an output from the analysis of data collected months 1 - 13)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel Greenwood, Anglia Ruskin University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS 307523
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Administered in Error
-
Hackensack Meridian HealthOmnicellCompletedMedication Compliance | Medication Administered in ErrorUnited States
-
NYU Langone HealthRecruitingMedication Administered in ErrorUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedMedication Administered in ErrorFrance
-
University of Southern DenmarkEnrolling by invitationMedication Administered in ErrorDenmark
-
National Healthcare Group, SingaporeCompletedMedication Adherence | Medication Administered in Error
-
Assistance Publique - Hôpitaux de ParisWithdrawnMedication Administered in Error
-
Brigham and Women's HospitalJohns Hopkins University; Massachusetts General Hospital; University of California... and other collaboratorsCompleted
-
Brigham and Women's HospitalNational Institute on Aging (NIA); Ideas42CompletedMedication Administered in Error | Antipsychotics and Neuroleptics ToxicityUnited States
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)RecruitingChild, Only | Medication Compliance | Medication Administered in Error | Disabilities Multiple | Medication InteractionUnited States
-
Western University, CanadaCentre for Addiction and Mental Health; London Health Sciences Centre; Texas... and other collaboratorsCompletedNurse's Role | Simulation of Physical Illness | Medication Administered in ErrorCanada